Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Co-administration of darunavir and a new pharmacokinetic booster: formulation strategies and evaluation in dogs.
Van Gyseghem E, Baert L, Van Remoortere P, van 't Klooster G, Rouan MC, Voorspoels J, de Kock H, Schueller L, Rosier J, Grooten L, Van den Mooter G. Van Gyseghem E, et al. Among authors: van den mooter g, van t klooster g, van remoortere p. Eur J Pharm Sci. 2010 Oct 9;41(2):193-200. doi: 10.1016/j.ejps.2010.05.017. Epub 2010 Jun 8. Eur J Pharm Sci. 2010. PMID: 20685614
Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
Van Gyseghem E, Pendela M, Baert L, Rosier J, Van 't Klooster G, De Man H, Bouche MP, Schueller L, Van Remoortere P, Wigerinck P, Adams E, Hoogmartens J, Van den Mooter G. Van Gyseghem E, et al. Among authors: van den mooter g, van t klooster g, van remoortere p. Eur J Pharm Biopharm. 2008 Nov;70(3):853-60. doi: 10.1016/j.ejpb.2008.06.030. Epub 2008 Jul 9. Eur J Pharm Biopharm. 2008. PMID: 18657611
Development of an implantable infusion pump for sustained anti-HIV drug administration.
Baert L, Schueller L, Tardy Y, Macbride D, Klooster Gv, Borghys H, Clessens E, Van Den Mooter G, Van Gyseghem E, Van Remoortere P, Wigerinck P, Rosier J. Baert L, et al. Among authors: van den mooter g, van gyseghem e, van remoortere p. Int J Pharm. 2008 May 1;355(1-2):38-44. doi: 10.1016/j.ijpharm.2008.01.029. Epub 2008 Jan 24. Int J Pharm. 2008. PMID: 18337029
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.
Baert L, van 't Klooster G, Dries W, François M, Wouters A, Basstanie E, Iterbeke K, Stappers F, Stevens P, Schueller L, Van Remoortere P, Kraus G, Wigerinck P, Rosier J. Baert L, et al. Among authors: van t klooster g, van remoortere p. Eur J Pharm Biopharm. 2009 Aug;72(3):502-8. doi: 10.1016/j.ejpb.2009.03.006. Epub 2009 Mar 27. Eur J Pharm Biopharm. 2009. PMID: 19328850
Dog model with implanted pump to test boosters for antiretroviral medication.
Schueller L, Baert L, Lachau-Durand S, Borghys H, Clessens E, Van Den Mooter G, Van Gyseghem E, Jonckers TH, Van Remoortere P, Wigerinck P, Rosier J. Schueller L, et al. Among authors: van den mooter g, van gyseghem e, van remoortere p. Int J Pharm. 2008 May 1;355(1-2):45-52. doi: 10.1016/j.ijpharm.2007.09.025. Epub 2007 Sep 25. Int J Pharm. 2008. PMID: 18082980
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
Reesink HW, Fanning GC, Farha KA, Weegink C, Van Vliet A, Van 't Klooster G, Lenz O, Aharchi F, Mariën K, Van Remoortere P, de Kock H, Broeckaert F, Meyvisch P, Van Beirendonck E, Simmen K, Verloes R. Reesink HW, et al. Among authors: van t klooster g, van beirendonck e, van vliet a, van remoortere p. Gastroenterology. 2010 Mar;138(3):913-21. doi: 10.1053/j.gastro.2009.10.033. Epub 2009 Oct 21. Gastroenterology. 2010. PMID: 19852962 Clinical Trial.
Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase.
Cummings MD, Lin TI, Hu L, Tahri A, McGowan D, Amssoms K, Last S, Devogelaere B, Rouan MC, Vijgen L, Berke JM, Dehertogh P, Fransen E, Cleiren E, van der Helm L, Fanning G, Nyanguile O, Simmen K, Van Remoortere P, Raboisson P, Vendeville S. Cummings MD, et al. Among authors: van der helm l, van remoortere p. J Med Chem. 2014 Mar 13;57(5):1880-92. doi: 10.1021/jm401396p. Epub 2013 Nov 8. J Med Chem. 2014. PMID: 24144360
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model.
Olszewska W, Ispas G, Schnoeller C, Sawant D, Van de Casteele T, Nauwelaers D, Van Kerckhove B, Roymans D, De Meulder M, Rouan MC, Van Remoortere P, Bonfanti JF, Van Velsen F, Koul A, Vanstockem M, Andries K, Sowinski P, Wang B, Openshaw P, Verloes R. Olszewska W, et al. Among authors: van velsen f, van de casteele t, van kerckhove b, van remoortere p. Eur Respir J. 2011 Aug;38(2):401-8. doi: 10.1183/09031936.00005610. Epub 2010 Dec 9. Eur Respir J. 2011. PMID: 21148224 Free article.
27 results